Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-11

Clinical Trial Update: Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring reversing tissue fibrosis to improve immune reconstitution in HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: HIV Infection, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2020-12-11